` SLP (Simulations Plus Inc) vs S&P 500 Comparison - Alpha Spread

SLP
vs
S&P 500

Over the past 12 months, SLP has underperformed S&P 500, delivering a return of -67% compared to the S&P 500's +16% growth.

Stocks Performance
SLP vs S&P 500

Loading
SLP
S&P 500
Add Stock
www.alphaspread.com

Performance Gap
SLP vs S&P 500

Loading
SLP
S&P 500
Difference
www.alphaspread.com

Performance By Year
SLP vs S&P 500

Loading
SLP
S&P 500
Add Stock

Competitors Performance
Simulations Plus Inc vs Peers

Simulations Plus Inc
Glance View

Market Cap
262.3m USD
Industry
Health Care

Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research and regulatory submissions. The company is headquartered in Lancaster, California and currently employs 135 full-time employees. The company provides prediction of properties of molecules utilizing artificial-intelligence- and machine-learning-based technology. The company also provides consulting services ranging from early drug discovery through preclinical and clinical trial development to regulatory submissions in support of product approval. The company offers 11 software products for pharmaceutical research and development, which includes GastroPlus, DDDPlus, MembranePlus, DILIsym, NAFLDsym, ADMET Predictor, MedChem Designer, MedChem Studio, PKPlus, KIWI and Monolix Suite of products through Lixoft. Its software and consulting services are provided to pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies and to academic and regulatory agencies worldwide for use in the conduct of industry-based research. Cognigen Corporation, DILIsym Services, Inc. and Lixoft are its subsidiaries.

SLP Intrinsic Value
14.26 USD
Undervaluation 9%
Intrinsic Value
Price
Back to Top